BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 22773607)

  • 21. Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain.
    Aranda N; Viteri FE; Montserrat C; Arija V
    Ann Hematol; 2010 Aug; 89(8):767-73. PubMed ID: 20107990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical expression of haemochromatosis in Irish C282Y homozygotes identified through family screening.
    Gleeson F; Ryan E; Barrett S; Crowe J
    Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):859-63. PubMed ID: 15316409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
    McLaren GD; Gordeuk VR
    Hematology Am Soc Hematol Educ Program; 2009; ():195-206. PubMed ID: 20008199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of H63D homozygosity in a Basque population with hemochromatosis.
    Castiella A; Zapata E; de Juan MD; Otazua P; Fernandez J; Zubiaurre L; Arriola JA;
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1295-8. PubMed ID: 20594259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.
    Aguilar-Martinez P; Grandchamp B; Cunat S; Cadet E; Blanc F; Nourrit M; Lassoued K; Schved JF; Rochette J
    Haematologica; 2011 Apr; 96(4):507-14. PubMed ID: 21228038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
    Barton JC; Wiener HW; Acton RT; Go RC
    Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
    Raddatz D; Legler T; Lynen R; Addicks N; Ramadori G
    Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population-based study of the clinical expression of the hemochromatosis gene.
    Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
    N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major histocompatibility complex class I associations in iron overload: evidence for a new link between the HFE H63D mutation, HLA-A29, and non-classical forms of hemochromatosis.
    Porto G; Alves H; Rodrigues P; Cabeda JM; Portal C; Ruivo A; Justiça B; Wolff R; De Sousa M
    Immunogenetics; 1998 Apr; 47(5):404-10. PubMed ID: 9510559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
    Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP
    Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemistry of the Hfe protein in patients with hereditary hemochromatosis, iron deficiency anemia, and normal controls.
    Byrnes V; Ryan E; O'Keane C; Crowe J
    Blood Cells Mol Dis; 2000 Feb; 26(1):2-8. PubMed ID: 10772870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study.
    Lim A; Speechley M; Adams PC
    Can J Gastroenterol Hepatol; 2014 Oct; 28(9):502-4. PubMed ID: 25314357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload.
    McLaren CE; Emond MJ; Subramaniam VN; Phatak PD; Barton JC; Adams PC; Goh JB; McDonald CJ; Powell LW; Gurrin LC; Allen KJ; Nickerson DA; Louie T; Ramm GA; Anderson GJ; McLaren GD
    Hepatology; 2015 Aug; 62(2):429-39. PubMed ID: 25605615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance.
    Milet J; Dehais V; Bourgain C; Jouanolle AM; Mosser A; Perrin M; Morcet J; Brissot P; David V; Deugnier Y; Mosser J
    Am J Hum Genet; 2007 Oct; 81(4):799-807. PubMed ID: 17847004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload.
    Porto G; Cardoso CS; Gordeuk V; Cruz E; Fraga J; Areias J; Oliveira JC; Bravo F; Gangaidzo IT; MacPhail AP; Gomo ZA; Moyo VM; Melo G; Silva C; Justiça B; de Sousa M
    Eur J Haematol; 2001 Aug; 67(2):110-8. PubMed ID: 11722599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study.
    Acton RT; Barton JC; Passmore LV; Adams PC; Speechley MR; Dawkins FW; Sholinsky P; Reboussin DM; McLaren GD; Harris EL; Bent TC; Vogt TM; Castro O
    Diabetes Care; 2006 Sep; 29(9):2084-9. PubMed ID: 16936157
    [TBL] [Abstract][Full Text] [Related]  

  • 37.  GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
    Levstik A; Stuart A; Adams PC
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.
    Acton RT; Barton JC; Leiendecker-Foster C; Zaun C; McLaren CE; Eckfeldt JH
    Blood Cells Mol Dis; 2010 Apr; 44(4):252-6. PubMed ID: 20178892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
    Press RD; Flora K; Gross C; Rabkin JM; Corless CL
    Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.